内克塔治疗 | 46.84 +2.84 +6.45% | ||
| NKTR | |||
| 高 47.12 | 开 44.10 | 量 102.10万股 | 总市值 9.53亿 |
| 低 43.62 | 换 5.02% | 额 4718.93万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
内克塔治疗(NKTR)
12-16 21:05
$内克塔治疗(NKTR)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-320009 Act: 34 Size: 17 MB 网页链接
内克塔治疗(NKTR)
11-26 09:35
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297855 Size: 10 KB 网页链接
内克塔治疗(NKTR)
11-26 09:35
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297850 Size: 11 KB 网页链接
内克塔治疗(NKTR)
11-26 09:35
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-297852 Size: 10 KB 网页链接
内克塔治疗(NKTR)
11-26 04:45
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-007276 Act: 33 Size: 7 KB 网页链接
内克塔治疗(NKTR)
11-26 04:35
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-007274 Act: 33 Size: 5 KB 网页链接
内克塔治疗(NKTR)
11-26 04:35
$内克塔治疗(NKTR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-007275 Act: 33 Size: 4 KB 网页链接
内克塔治疗(NKTR)
11-22 05:15
$内克塔治疗(NKTR)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001213900-25-113606 Act: 34 Size: 189 KB 网页链接
内克塔治疗(NKTR)
11-15 05:45
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-112619 Act: 34 Size: 11 KB 网页链接
内克塔治疗(NKTR)
11-15 05:35
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-283066 Act: 34 Size: 11 KB 网页链接
内克塔治疗(NKTR)
11-14 06:55
$内克塔治疗(NKTR)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001446580-25-000123 Act: 34 Size: 12 KB 网页链接
内克塔治疗(NKTR)
11-13 05:25
$内克塔治疗(NKTR)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-25-109222 Act: 33 Size: 383 KB 网页链接
内克塔治疗(NKTR)
11-13 05:15
$内克塔治疗(NKTR)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001193125-25-277535 Act: 33 Size: 1 MB 网页链接
内克塔治疗(NKTR)
11-13 05:15
$内克塔治疗(NKTR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-277570 Act: 33 Size: 457 KB 网页链接
内克塔治疗(NKTR)
11-10 19:35
$内克塔治疗(NKTR)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-25-107821 Act: 34 Size: 241 KB 网页链接
内克塔治疗(NKTR)
11-07 19:05
$内克塔治疗(NKTR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-270230 Act: 34 Size: 10 MB 网页链接
内克塔治疗(NKTR)
11-07 05:35
$内克塔治疗(NKTR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-25-107180 Act: 34 Size: 309 KB 网页链接
内克塔治疗(NKTR)
10-31 23:15
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-25-000266 Act: 34 Size: 6 KB 网页链接
内克塔治疗(NKTR)
10-29 04:15
$内克塔治疗(NKTR)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-103174 Act: 34 Size: 18 KB 网页链接
内克塔治疗(NKTR)
10-02 07:55
$内克塔治疗(NKTR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-227232 Size: 5 KB 网页链接